560.65
+18.50
+(3.41%)
At close: January 24 at 3:30:03 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
Operating Cash Flow
-198,710.00
-198,710.00
-10,790.00
-104,470.00
Investing Cash Flow
-546,570.00
-546,570.00
-482,870.00
-244,400.00
Financing Cash Flow
869,810.00
869,810.00
462,510.00
364,620.00
End Cash Position
130,550.00
130,550.00
1,000.00
32,150.00
Capital Expenditure
-518,250.00
-518,250.00
-472,770.00
-106,820.00
Issuance of Capital Stock
369,930.00
369,930.00
26,820.00
240,210.00
Free Cash Flow
-716,960.00
-716,960.00
-483,560.00
-211,290.00
3/31/2022 - 12/30/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MARKSANS.NS Marksans Pharma Limited
252.60
-0.71%
KOPRAN.NS Kopran Limited
199.08
-3.10%
CIPLA.NS Cipla Limited
1,411.40
-2.74%
JNJ.NE JOHNSON & JOHNSON CDR (CAD HEDG
19.51
+0.26%
BIIB Biogen Inc.
146.20
+1.76%
GILD Gilead Sciences, Inc.
93.07
+0.16%
PFE Pfizer Inc.
26.09
+0.31%
JNJ Johnson & Johnson
146.82
+0.12%